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ABSTRACT
Background: We developed skin prick test (SPT) reagents for common inhalant allergens that 
reflected the real exposure in Korea. The study aim was to evaluate diagnostic usefulness and 
allergen potency of our inhalant SPT reagents in comparison with commercial products.
Methods: We produced eight common inhalant allergen SPT reagents using total extract 
(Prolagen): Dermatophagoides farinae, Dermatophagoides pteronyssinus, oak, ragweed, mugwort, 
Humulus japonicus pollens, as well as cat and dog allergens. We compared the newly developed 
reagents with three commercially available SPT reagents (Allergopharma, Hollister-Stier, 
Lofarma). We measured total protein concentrations, sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis (SDS-PAGE), major allergen concentration, and biological allergen potencies 
measured by immunoglobulin E (IgE) immunoblotting and ImmunoCAP inhibition test.
Results: Diagnostic values of these SPT reagents were expressed as positivity rate and 
concordance rate of the results from ImmunoCAP allergen-specific IgE test in 94 allergic 
patients. In vitro analysis showed marked differences in protein concentrations, SDS-PAGE 
features, major allergen concentrations, and biological allergen potencies of four different 
SPT reagents. In vivo analysis showed that positive rates and concordance rates of Prolagen® 
SPT reagents were similar compared to the three commercial SPT reagents.
Conclusion: The newly developed Prolagen® inhalant SPT reagents are not inferior to the 
commercially available SPT reagents in allergy diagnosis.
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INTRODUCTION
Identification of allergen sensitization is important for the diagnosis and treatment of 
allergic diseases. Skin prick test (SPT) has been regarded as major standard method for 
identification of causative allergens in patients with allergic diseases.1 However, studies 
evaluating different SPT reagents in their in vitro biological allergen potency and protein 
characteristics, as well as in vivo diagnostic value, are scarce.2,3
J Korean Med Sci. 2018 Mar 26;33(13):e101
https://doi.org/10.3346/jkms.2018.33.e101
eISSN 1598-6357·pISSN 1011-8934
Original Article
Received: Sep 26, 2017
Accepted: Jan 19, 2018
Address for Correspondence:
Jung-Won Park, MD, PhD
Division of Allergy and Immunology, 
Department of Internal Medicine, Yonsei 
University College of Medicine, 50-1 Yonsei-ro, 
Seodaemun-gu, Seoul 03722, Korea.
E-mail: PARKJW@yuhs.ac
© 2018 The Korean Academy of Medical 
Sciences.
This is an Open Access article distributed 
under the terms of the Creative Commons 
Attribution Non-Commercial License (https://
creativecommons.org/licenses/by-nc/4.0/) 
which permits unrestricted non-commercial 
use, distribution, and reproduction in any 
medium, provided the original work is properly 
cited.
ORCID iDs
Sang Chul Lee 
https://orcid.org/0000-0001-5318-6804
Da Woon Sim 
https://orcid.org/0000-0002-9723-0720
Jongsun Lee 
https://orcid.org/0000-0003-1526-2241
Kyoung Yong Jeong 
https://orcid.org/0000-0001-9887-1426
Kyung Hee Park 
https://orcid.org/0000-0003-3605-5364
Jae-Hyun Lee 
https://orcid.org/0000-0002-0760-0071
Jung Dong Kim 
https://orcid.org/0000-0002-6348-9267
Sang Chul Lee ,1,2 Da Woon Sim ,3 Jongsun Lee ,2 Kyoung Yong Jeong ,2  
Kyung Hee Park ,1,2 Jae-Hyun Lee ,1,2 Jung Dong Kim ,4 and Jung-Won Park  1,2,4
1 Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of 
Medicine, Seoul, Korea
2Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea
3 Division of Allergy, Department of Internal Medicine, Chonnam National University Medical School, 
Gwangju, Korea
4Prolagen, Seoul, Korea
Comparison between Newly 
Developed and Commercial Inhalant 
Skin Prick Test Reagents Using In Vivo 
and In Vitro Methods
Immunology, Allergic 
Disorders & Rheumatology
Jung-Won Park 
https://orcid.org/0000-0003-0249-8749
Funding
This research was supported by a grant from 
the Korea Healthcare Technology R & D Project 
through Korean Health Industry Development 
Institute, which is funded by Republic of 
Korea's Ministry of Health and Welfare 
(HI14C1324).
Disclosure
Dr. Park JW reports serving as an unpaid chief 
technology officer for Prolagen; Dr. Kim JD, 
serving as chief executive officer for Prolagen. 
Dr. Park JW, Dr. Kim JD, Dr. Park KH, having 
an equity interest in Prolagen. These authors' 
interests did not influence academic fairness 
in conducting this study, analyzing results, 
and writing a paper. Other authors have no 
potential conflicts of interest to disclose.
Author Contributions
Conceptualization: Park JW, Lee JH, Park 
KH. Methodology: Lee J, Jeong KY, Sim DW. 
Product manufacturer: Kim JD. Data curation: 
Lee SC. Formal analysis: Sim DW, Lee SC. 
Investigation: Lee SC. Software: Lee SC. 
Validation: Lee SC. Writing - original draft: Lee 
SC. Writing - review & editing: Park JW.
Manufacturers of SPT products maintain their own quality control programs and allergen 
potency units for their reagents. These may cause differences in allergen potency and 
clinical validity of the products.4,5 In this context, standardization of SPT reagents should be 
warranted.6,7
In Korea, three manufacturers (two European and one American company) have provided 
SPT reagents. However, the products may not reflect real exposure in Asian countries, 
including Korea. For example, white oak, which is used as raw material in commercial 
reagents, is not found in Korea, where sawtooth and Mongolian oak trees are the dominant 
species.8,9 The discrepancy between used raw material and real exposure may affect the 
diagnostic rate of oak pollinosis in Korea. Additionally, various house dust mite (HDM) 
isoallergens have been reported to be dominant in each country, and the diagnostic value 
may be affected by the types of isoallergen used in each SPT reagent.9 In this regard, 
development of SPT reagents that reflect the real allergen exposure in Korean environment is 
urgently needed.
Recently, we developed SPT reagents for 8 respiratory allergens that reflect real exposure of 
Korea.10 In this study, we compared allergen characteristics and clinical efficacy of the new 
SPT reagents using three different commercially available SPT reagents.
METHODS
Trial design
This prospective, double-blind study was permitted by the Institutional Review Board of 
Severance Hospital, Seoul, Korea. We explored biological activities of 8 different kinds of 
total extract allergen SPT reagents (Dermatophagoides farinae, Dermatophagoides pteronyssinus, 
pollens of oak, ragweed, mugwort, Humulus japonicus, cat and dog allergens) from four 
different manufacturers.
Patient selection
For this study, 94 respiratory allergic patients were enrolled from 109 preselected candidates. 
Patients with acute asthma exacerbation, severe skin diseases, and chronic diseases (such 
as autoimmune disease, immune deficiency and cancer), or those who were pregnant were 
excluded. The use of antihistamines, systemic corticosteroids (≥ 20 mg/day), and topical 
steroid was discontinued for at least seven days before testing.
Allergen extracts
We compared newly developed SPT reagents (Prolagen, Seoul, Korea) with three different 
commercial products (Hollister-Stier, Spokane, WA, USA; Allergopharma, Reinbek, 
Germany; Lofarma, Milano, Italy). To manufacture new SPT product, allergen extracts were 
prepared as previously described (HDM and pollen extracts).11-13 In particular, we used 
sawtooth oak as the raw material of oak reagent. In respect of dog and cat, hair and dander 
were collected from designated animal hospitals. Both dogs and cats were trimmed before 
shampooing. Allergen extracts were prepared in ammonium bicarbonate buffer (pH 8.0) 
after defatting with ethyl ether. Subsequently, the extracts were dialyzed against distilled 
water, syringe filtered (0.22 μm; Millipore, Bedford, MA, USA), and lyophilized. Finally, each 
reagent was stored in 50% glycerinated, 0.3% phenol saline.
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SPT
SPT was performed with a 26-gauge needle on the upper back of patients by one experienced 
technician. Histamine (1.7 mg/mL in 0.3% phenol saline; Allergopharma) and saline were 
used as positive and negative controls, respectively. Wheals and flares, induced by the allergen 
and histamine, were measured 15 minutes after prick. SPT was considered positive if wheal 
diameter was ≥ 3 mm. Negative control must have shown no reaction. In addition to SPT, 
serum-specific immunoglobulin E (sIgE) levels in response to each allergen were measured 
using ImmunoCAP (Thermo Fisher Scientific, Uppsala, Sweden). Serum was stored at −20°C 
before ImmunoCAP measurement. The results were calculated in kU/L for immunoglobulin E 
(IgE) antibodies, and sIgE antibody values ≥ 0.35 kU/L were considered positive.
In vitro analysis of each reagent
To measure the protein concentration of the reagents, Bradford assay was used, and their 
integrity was assessed through Coomassie staining in sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis (SDS-PAGE). Meanwhile, concentrations of each major allergen in SPT 
reagents were measured by two-site enzyme-linked immunosorbent assay (ELISA). For 
biological allergen potency evaluations, IgE immunoblotting using pooled sera from allergic 
patients. In addition, inhibition ImmunoCAP test was used to measure the 50% inhibitory 
concentration of each allergen.
Statistical analysis
Statistical comparison was conducted using IBM SPSS Statistics Version 23 (IBM Co., Armonk, 
NY, USA). Cohen's Kappa analysis was utilized to assess the diagnostic concordance rate of SPT 
reagents with ImmunoCAP. Kappa values were interpreted as follows: almost perfect (0.8–1.0), 
substantial (0.6–0.8), moderate (0.4–0.6), fair (0.2–0.4), and poor (< 0.2).14 P values < 0.05 
were considered statistically significant.
Ethics statement
The present study protocol was reviewed and approved by the Institutional Review Board 
of Severance Hospital (approval No. 4-2015-0240). Informed consent was submitted by all 
subjects when they were enrolled.
RESULTS
Demographic data of study patients
Ninety-four patients with allergic diseases (bronchial asthma, allergic rhinitis, chronic 
urticarial, and anaphylaxis) were enrolled in this study to compare in vivo diagnostic 
properties of the reagents. Demographic data are shown in Table 1. Sixty-one patients 
(64.9%) were polysensitized to two or more allergens, and allergic rhinitis was the most 
common allergic disease.
SPT positivity and concordance rates compared with the ImmunoCAP results
Comparison of SPT results is shown in Table 2. Overall, positivity of newly developed 
Prolagen SPT was similar to that of commercial reagents, except for higher rate of Prolagen 
SPT shown in oak, ragweed, H. japonicus pollens, and cat allergen.
Concordance between the results of SPT reagents and serum sIgE levels is also shown in 
Table 2. Level of agreement between sIgE level and results of Prolagen SPT reagents were 
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almost perfect for mugwort pollen (kappa 0.849), substantial for oak pollen (kappa 0.670), 
moderate for D. farinae, D. pteronyssinus, H. japonicus, ragweed, and dog (kappa 0.402–0.591), 
and fair for cat (kappa 0.346). Concordance rates of four different SPT reagents in each 
allergen, except ragweed reagent by Lofarma, were not significantly different.
As the oak ImmunoCAP used white oak pollen as raw material, we coated the empty solid 
phase of ImmunoCAP with sawtooth pollen extract, and compared concordance rates of 
four SPT reagents. Fig. 1 shows scattered graph of the two measurements using 71 atopic 
sera. However, results of ImmunoCAP using both raw materials were almost equivalent. 
Concordance rates of four SPT reagents were also similar whether white oak or sawtooth oak 
pollens were used as raw material for ImmunoCAP (Table 3).
In vitro analysis of each reagent
Results of protein quantification for each SPT reagents are shown in Table 4. In the case of  
D. farinae, D. pteronyssinus, and ragweed, Hollister-Stier was the highest. Other than those 
HDM allergens, Prolagen reagents showed the highest protein quantity.
For SDS-PAGE analysis, we uploaded equal volumes of SPT reagents to compare the protein 
contents that were applied to patients. SDS-PAGE features showed marked differences 
among the SPT reagents. Prolagen SPT reagents had especially strong SDS-PAGE bands for 
HDMs, oak, H. japonicus, and dog. Hollister-Stier SPT reagents had especially strong bands 
for ragweed pollen, and Lofarma SPT reagents had especially strong bands for mugwort 
pollen (Fig. 2).
Fig. 3 shows IgE immunoblotting features. Overall trend was similar to SDS-PAGE. 
Especially, for HDMs, ragweed, mugwort, H. japonicus, cat and dog allergens, Prolagen SPT 
reagents showed stronger IgE-binding than other reagents.
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Table 1. Baseline characteristics of participants
Parameters No. (%) of patients (n = 94)
Age, yr 35.9 ± 13.4
Sex
Female 54 (57.4)
Male 40 (42.6)
Sensitized allergen
D. farinae 57 (60.6)
D. pteronyssinus 62 (65.9)
Oak 21 (22.3)
Ragweed 18 (19.1)
Mugwort 19 (20.2)
H. japonicus 16 (17.0)
Cat allergen 24 (25.5)
Dog allergen 26 (27.7)
Atopy
Non-atopy 30 (31.9)
Monosensitization 3 (3.2)
Polysensitization 61 (64.9)
Clinical diagnosis
Asthma 63 (67.0)
Allergic rhinitis 82 (87.2)
Chronic urticaria 5 (5.3)
Anaphylaxis 5 (3.2)
Atopic dermatitis 3 (3.2)
Data are shown as mean ± standard deviation or number (%).
Two-site ELISA measurements for major allergens within the reagents were also measured 
(Fig. 4). For HDM group 1 and 2 major allergens, Hollister-Stier and Prolagen reagents were 
higher compared to the others. In regards to group 1 major allergen of cat and dog, Hollister-
Stier and Prolagen reagents had excellent level of allergen component, respectively.
Finally, channel-activating protease (CAP) inhibition study was used to evaluate the total 
allergen potency per protein content of SPT reagents (Fig. 5). Total allergen potencies per 
protein content of four different SPT reagents were similar, except for low allergen potency 
observed in Prolagen cat and dog reagents. CAP inhibition study showed outstanding 
allergenicity for cat SPT of Hollister-Stier, and dog SPT of Lofarma. Despite high protein 
concentration in Prolagen product, total allergen potency of cat and dog SPT reagents were low.
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Table 2. SPT positivity and concordance rates compared with ImmunoCAP results
Allergens Products Results Agreement Kappa analysis
Negative Positive Positive,  
%
Negative,  
%
Positive,  
%
Total,  
% (agree/total)
κ P value
D. farinae ImmunoCAP 43 51 54.3 - - - - -
Hollister-Stier 31 63 67.0 71 80 77 (72/94) 0.520 < 0.001
Allergopharma 39 55 58.5 80 83 82 (77/94) 0.635 < 0.001
Lofarma 31 63 67.0 77 82 80 (75/94) 0.589 < 0.001
Prolagen 35 59 62.8 74 85 81 (76/94) 0.591 < 0.001
D. pteronyssinus ImmunoCAP 37 57 60.6 - - - - -
Hollister-Stier 33 61 64.9 74 85 81 (76/94) 0.587 < 0.001
Allergopharma 42 52 55.3 76 84 81 (76/94) 0.603 < 0.001
Lofarma 38 56 59.6 76 87 83 (78/94) 0.633 < 0.001
Prolagen 35 59 62.8 74 85 81 (76/94) 0.591 < 0.001
Oak ImmunoCAP 76 18 19.1 - - - - -
Hollister-Stier N/A N/A N/A N/A N/A N/A N/A N/A
Allergopharma 77 17 18.1 95 80 93 (87/94) 0.754 < 0.001
Lofarma 76 18 19.1 96 83 94 (88/94) 0.794 < 0.001
Prolagen 74 20 21.3 93 94 89 (84/94) 0.670 < 0.001
Ragweed ImmunoCAP 77 17 18.1 - - - - -
Hollister-Stier 82 12 12.8 92 55 86 (81/94) 0.473 < 0.001
Allergopharma 83 11 11.7 91 50 85 (80/94) 0.417 < 0.001
Lofarma 85 9 9.6 89 31 81 (76/94) 0.209 0.072
Prolagen 77 17 18.1 91 59 85 (80/94) 0.497 < 0.001
Mugwort ImmunoCAP 78 16 17.0 - - - - -
Hollister-Stier 78 16 17.0 96 81 94 (88/94) 0.774 < 0.001
Allergopharma 78 16 17.0 97 88 96 (90/94) 0.849 < 0.001
Lofarma 77 17 18.1 95 79 93 (87/94) 0.743 < 0.001
Prolagen 78 16 17.0 97 88 96 (90/94) 0.849 < 0.001
H. japonicus ImmunoCAP 80 14 14.9 - - - - -
Hollister-Stier N/A N/A N/A N/A N/A N/A N/A N/A
Allergopharma 74 20 21.3 90 53 83 (78/94) 0.429 <0.001
Lofarma N/A N/A N/A N/A N/A N/A N/A N/A
Prolagen 71 23 24.5 90 59 84 (79/94) 0.502 < 0.001
Cat allergen ImmunoCAP 73 21 22.3 - - - - -
Hollister-Stier 59 36 38.3 84 63 78 (73/94) 0.487 < 0.001
Allergopharma N/A N/A N/A N/A N/A N/A N/A N/A
Lofarma 69 25 26.6 87 61 81 (76/94) 0.483 < 0.001
Prolagen 49 45 47.9 75 55 68 (64/94) 0.346 < 0.001
Dog allergen ImmunoCAP 72 22 23.4 - - - - -
Hollister-Stier 66 28 29.8 83 52 74 (70/94) 0.367 < 0.001
Allergopharma N/A N/A N/A N/A N/A N/A N/A N/A
Lofarma 63 31 33.0 83 57 76 (71/94) 0.349 < 0.001
Prolagen 67 27 28.7 83 53 74 (71/94) 0.402 < 0.001
SPT = skin prick test, N/A = not available.
DISCUSSION
As we mentioned above, discrepancies in allergen potency between commercial SPT reagents 
have been already reported.5,15 We compared 8 kinds of SPT reagents from 4 different 
manufacturers about their allergenic contents, allergenicity, and clinical validity using in vitro 
and in vivo methods.
Regarding HDMs, Hollister-Stier had the highest amount of protein among all products. 
This feature was consistent to the result of two-site ELISA measurement of groups 1 and 2 of 
major HDM allergens. Although marked differences were observed in their in vitro results, 
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Fig. 1. Scatter plot comparing sIgE levels of sawtooth oak (x-axis) and white oak (y-axis). 
sIgE = specific immunoglobulin E.
Table 3. Comparison of concordance rates between oak SPT reagents and sIgE measurement by white oak or sawtooth oak coated ImmunoCAP
Allergens coated to 
ImmunoCAP
Products Agreement Kappa analysis
Negative, % Positive, % Total, % (agree/total) κ P value
Sawtooth oak Hollister-Stier N/A N/A N/A N/A N/A
Allergopharma 96.5 75.0 91.8 (68/74) 0.749 < 0.001
Lofarma 94.8 93.7 94.5 (70/74) 0.847 < 0.001
Prolagen 91.3 68.7 86.5 (64/74) 0.601 < 0.001
White oak Hollister-Stier N/A N/A N/A N/A N/A
Allergopharma 98.2 76.4 93.2 (69/74) 0.796 < 0.001
Lofarma 96.4 94.1 95.9 (71/74) 0.888 < 0.001
Prolagen 92.9 70.5 87.8 (65/74) 0.649 < 0.001
SPT = skin prick test, sIgE = specific immunoglobulin E, N/A = not available.
Table 4. Protein concentrations for SPT reagents of each allergen
Allergens Protein concentration, µg/mL
Hollister-Stier Allergopharma Lofarma Prolagen
D. farinae 2,035.4 94.9 572.7 915.9
D. pteronyssinus 1,283.5 87.8 173.1 753.5
Oak N/A 175.6 226.6 801.8
Ragweed 3,243.9 174.8 519.1 994.6
Mugwort N/A 400.4 408.8 927.0
H. japonicus N/A 180.8 N/A 802.1
Cat allergen 24.4 N/A 18.2 102.5
Dog allergen 17.8 N/A 33.3 189.6
SPT = skin prick test, N/A = not available.
diagnostic accuracy of concordance rates between SPT and ImmunoCAP did not show any 
significant differences among the SPT reagents.
Prolagen reagent showed excellent overall in vitro results in regards to oak allergen. However, 
in vivo data, such as concordance rate or kappa value, was relatively lower than those of 
other 2 reagents. We presumed that the differences between Prolagen product and the 
others might originate from the difference in raw materials used. Commercial SPT and 
ImmunoCAP products have used white oak as raw material, whereas Prolagen product was 
made of sawtooth oak pollen extract. Previously, Jeong et al.8 revealed that Mongolian oak 
and sawtooth oak are the dominant species in Korea, although the study also reported strong 
cross-reactivity between Fagaceae family (sawtooth oak, Mongolian oak, white oak, and birch 
pollens). Therefore, we also compared the concordance rates between white or sawtooth 
oaks pollen extract coated ImmunoCAP sIgE tests and the SPT, and found that the results 
were almost equivalent whether saw tooth or white oak were used for ImmunoCAP.
In the case of ragweed pollen SPT reagents, protein concentration of Hollister-Stier 
was overwhelmingly high. However, the concordance rate of Hollister-Stier was not any 
noticeable differences from Allergopharma and Prolagen products.
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Fig. 2. SDS-PAGE features of SPT reagents for each allergen. (A) D. farinae, (B) D. pteronyssinus, (C) oak, (D) ragweed, (E) mugwort, (F) H. japonicus, (G) cat 
allergen, (H) dog allergen. 
SDS-PAGE = sodium dodecyl sulphate-polyacrylamide gel electrophoresis, SPT = skin prick test, M = Marker, A = Allergopharma, L = Lofarma, H = Hollister-Stier, 
P = Prolagen.
For mugwort pollen, Allergopharma and Prolagen products showed better results than the 
other products. In Korea, mugwort is especially important as weed pollinosis, and it is worth 
noticing that Prolagen product has high diagnostic value.
H. japonicus, a weed belonging to the Cannabis family and Urticales order, is one of the 
principal allergenic plants that induce pollinosis between mid-August and late September.16-18 
Furthermore, the sensitization rate in Korea may increase due to climate change.19 We compared 
new reagent with that of Allergopharma, which was the only commercially-available reagent in 
Korea. Our result showed that Prolagen SPT reagent had higher protein content determined by 
Bradford and SDS-PAGE, but the concordance rates were equivalent to each other.
In regards to cat allergen, Hollister-Stier showed the highest level of Fel d 1 and better allergenicity 
than the other reagents. On the other hand, Prolagen reagent's allergenicity and concordance 
rate with ImmunoCAP were lower compared to other 2 reagents, despite of higher protein 
concentration of Prolagen SPT reagent. Similar pattern was found at dog allergen. Prolagen 
product displayed significantly higher protein concentration and Can f 1 concentrations, while 
CAP inhibition results showed weak allergenicity per protein concentration compared to the 
other products. For dog allergen, in addition to group 1 major allergen, group 2 and 5 major 
allergens are also important.20 These results may have been caused by the use of only trimmed 
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Fig. 3. IgE immunoblotting features of the SPT reagents using the pooled serum of atopic patients (n = 5). (A) D. farinae, (B) D. pteronyssinus, (C) oak, (D) ragweed, 
(E) mugwort, (F) H. japonicus, (G) cat allergen, (H) dog allergen. 
IgE = immunoglobulin E, SPT = skin prick test, M = Marker, A = Allergopharma, L = Lofarma, H = Hollister-Stier, P = Prolagen.
hair of cat and dog from animal hospital, unlike other companies that collected hair and dander 
by extensive scrubbing with razor. Our study showed significant variation in allergen potency 
among the companion animal SPT extracts, which was consistent with the finding of Curin 
et al.21 who reported that variability in SPT reagents had a negative influence on the diagnosis 
of dog allergy. Despite of the abovementioned results, concordance rate of Prolagen product, 
compared to ImmunoCAP, was not inferior to the other products.
Findings of the current study can provide clinically important information to Korean 
allergists. Although comparison between SPT and CAP systems have been performed before, 
any comparison study among the commercially available inhalation allergen SPT reagents 
in Korea was not conducted.22 Additionally, considering that all reagents for diagnosis and 
immunotherapy is dependent on imports, this study also serves as an inspiring attempt to 
develop Korean SPT reagents that can reflect the unique Korean environment.8,23
However, our study had some limitations. We did not consider the differences in vehicle 
characteristics of SPT reagents. Possibility of degradation resulting from storage condition and 
duration of storage also has not been considered in this study, even the reagents were evaluated 
within the documented expiration date. Moreover, Prolagen product has not been formally 
approved for marketing; therefore, it cannot be currently applied in the clinical field. In order for 
Prolagen product to be used in clinical settings, further well-designed clinical trials are required.
In conclusion, there are differences in allergenic potency and concentration of major 
allergens among SPT reagents. This study confirmed that, when it comes to the diagnosis of 
respiratory allergic diseases, newly developed Prolagen SPT reagents are not inferior to the 
commercial reagents.
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Fig. 5. CAP inhibition results for each allergen. (A) D. farinae, (B) D. pteronyssinus, (C) oak, (D) ragweed, (E) mugwort, (F) H. japonicus, (G) cat allergen, (H) dog 
allergen. 
CAP = channel-activating protease.
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